Skip to main navigation Skip to search Skip to main content

Clinical trials eligibility of patients with malignant pleural mesothelioma: use of novel therapies and outcomes

Brandon Lau*, Michael Boyer, Jenny H. Lee, Steven Kao

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    6   Link opens in a new tab Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Clinical trials eligibility of patients with malignant pleural mesothelioma: use of novel therapies and outcomes'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science